Expansion of cytolytic CD4+CD28- T cells in end-stage renal disease

Kidney International

Volumn 74, Issue 6, 2008, Pages 760-767

  Betjes, Michiel G H ^a   Huisman, Martin ^a   Weimar, Willem ^a   Litjens, Nicolle H R ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Atherosclerosis; CD28; CD4+ T cell; Cytomegalovirus; End stage renal disease

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IONOMYCIN; VIRUS ANTIGEN;

ADULT; AGE; AGED; AGING; ANTIBODY TITER; ARTICLE; ATHEROSCLEROSIS; CD4+ CD28+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; DEGRANULATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; VIRUS REACTIVATION;

ADULT; AGE FACTORS; AGED; ANTIGENS, CD28; ANTIGENS, VIRAL; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CELL DEGRANULATION; CELL PROLIFERATION; CYTOMEGALOVIRUS; FEMALE; HUMANS; INTERFERON-GAMMA; KIDNEY FAILURE, CHRONIC; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; T-LYMPHOCYTES, CYTOTOXIC;

EID: 50849124444     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.301     Document Type: Article

References (27)

1. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
2. Shlipak MG, Fried LF, Cushman M et al. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. J Am Med Assoc 2005; 293: 1737-1745.
3. Menon V, Gaul A, Sarnak MJ. Cardiovascular risk factors in chronic kidney disease. Kidney Int 2005; 68: 1413-1418.
4. Betjes MGH, Litjens NHR, Zietse R. Seropositivity for cytomegalovirus in patients with end-stage renal disease is strongly associated with atherosclerotic disease. Nephrol Dial Transplant 2007; 22: 3298-3303.
5. Litjens NHR, van Druningen CJ, Betjes MGH. Progressive loss of renal function is associated with activation and depletion of naive T lymphocytes. Clin Immunol 2006; 118: 83-91.
6. Sylwester AW, Mitchell BL, Edgar JB et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 2005; 202: 673-685.
7. Hooper M, Kallas EG, Coffin D et al. Cytomegalovirus seropositivity is associated with the expansion of CD4+CD28- and CD8+CD28- T cells in rheumatoid arthritis. J Rheumatol 1999; 26: 1452-1457.
8. van Leeuwen EM, Remmerswaal EB, Vossen MT et al. Emergence of a CD4posCD28null granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J Immunol 2004; 173: 1834-1841.
9. Weinberger B, Lazuardi L, Weiskirchner I et al. Healthy aging and latent infection with CMV lead to distinct changes in CD8+ and CD4+ T-cell subsets in the elderly. Hum Immunol 2007; 68: 86-90.
10. Liuzzo G, Kopecky SL, Frye RL et al. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation 1999; 100: 2135.
11. Liuzzo G, Goronzy JJ, Yang H et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 2000; 101: 2883.
12. Sato K, Niessner A, Kopecky S et al. TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque. J Exp Med 2006; 203: 239-250.
13. + T lymphocytes depend on infection with CMV. J Immunol 2003; 170: 4342.
14. + T cells specific for defined antigens according to CD154 expression. Nat Med 2005; 11: 1118-1124.
15. Nowik M, Nowacki P, Grabarek J et al. Can we talk about CD4posCD28null lymphocytes as a risk factor for ischemic stroke? Eur Neurol 2007; 58: 26-33.
16. Vescovini R, Biasini C, Fagnoni FF et al. Massive load of functional effector CD4+ and CD8+ T cells against cytomegalovirus in very old subjects. J Immunol 2007; 179: 4283-4291.
17. + T cells in healthy carriers are continuously driven to replicative exhaustion. J Immunol 2005; 175: 8218-8225.
18. + T lymphocytes with cellular maturation. J Exp Med 2006; 203: 2865-2877.
19. Falagas ME, Griffiths J, Prekezes J et al. Cytomegalovirus colitis mimicking colon carcinoma in an HIV-negative patient with chronic renal failure. Am J Gastroenterol 1996; 91: 168-169.
20. Hardiman AE, Butter KC, Roe CJ et al. Cytomegalovirus infection in dialysis patients. Clin Nephrol 1985; 23: 12-17.
21. Van Leeuwen EM, de Bree GJ, Remmerswaal EB et al. IL-7 receptor alpha chain expression distinguishes functional subsets of virus-specific human CD8+ T cells. Blood 2005; 106: 2091-2098.
22. Huppert FA, Solomou W, O'Connor S et al. Aging and lymphocyte subpopulations: whole-blood analysis of immune markers in a large population sample of healthy elderly individuals. Exp Gerontol 1996; 33: 593-600.
23. Khan N, Hislop A, Gudgeon N et al. Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection. J Immunol 2004; 173: 7481-7489.
24. Trzonkowski P, Mysliwska J, Szmit E et al. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination - an impact of immunosenescence. Vaccine 2003; 21: 3826-3836.
25. Verkade MA, van de Wetering J, Klepper M et al. GM-CSF reduces the number of circulating dendritic cells in hemodialysis patients while enhancing the efficacy of hepatitis B vaccination. Kidney Int 2004; 66: 614-621.
26. + T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003; 281: 65-78.
27. Litjens NHR, Huisman M, Baan CC et al. Hepatitis B vaccine-specific CD4(+) T cells can be detected and characterised at the single cell level: limited usefulness of dendritic cells as signal enhancers. J Immunol Methods 2008; 330: 1-11.